Bayer reports Phase III results for investigational I 124 evuzamitide in cardiac amyloidosis, with primary endpoints met for visual PET scan interpretation.
Nottingham University Hospitals NHS Trust (NUH) has become the first site in the UK to install a photon-counting CT scanner with integrated laser-guided intervention.
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.